Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy

Q Li, S Geng, H Luo, W Wang, YQ Mo, Q Luo… - … and Targeted Therapy, 2024 - nature.com
Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality
worldwide. Its complexity is influenced by various signal transduction networks that govern …

Boron agents for neutron capture therapy

K Hu, Z Yang, L Zhang, L Xie, L Wang, H Xu… - Coordination Chemistry …, 2020 - Elsevier
Boron neutron capture therapy (BNCT) is a potential cancer radiotherapeutic modality,
which takes advantage of the neutron capture response that occurs when boron (10 B) is …

AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label …

Y Zhao, G Chen, J Chen, L Zhuang, Y Du, Q Yu… - …, 2023 - thelancet.com
Background Inhibiting vascular endothelial growth factor (VEGF) function can improve the
efficacy of immunotherapy by modulating the tumor immune microenvironment. AK112 is the …

Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1α/ROS/VEGF

J Cheng, HL Yang, CJ Gu, YK Liu… - International …, 2019 - spandidos-publications.com
Angiogenesis is an essential process involved in various physiological, including
placentation, and pathological, including cancer and endometriosis, processes. Melatonin …

Engineering nanosystems to overcome barriers to cancer diagnosis and treatment

SO Alhaj-Suliman, EI Wafa, AK Salem - Advanced drug delivery reviews, 2022 - Elsevier
Over the past two decades, multidisciplinary investigations into the development of
nanoparticles for medical applications have continually increased. However, nanoparticles …

[HTML][HTML] Vascular complications of cancer chemotherapy

AC Cameron, RM Touyz, NN Lang - Canadian Journal of Cardiology, 2016 - Elsevier
Abstract Development of new anticancer drugs has resulted in improved mortality rates and
5-year survival rates in patients with cancer. However, many of the modern chemotherapies …

Serotonin in the gut: Blessing or a curse

S Banskota, JE Ghia, WI Khan - Biochimie, 2019 - Elsevier
Abstract Serotonin (5-hydroxytryptamine or 5-HT) once most extensively studied as a
neurotransmitter of the central nervous system, is seen to be predominantly secreted in the …

A review of anti-angiogenic targets for monoclonal antibody cancer therapy

DH Kong, MR Kim, JH Jang, HJ Na, S Lee - International journal of …, 2017 - mdpi.com
Tumor angiogenesis is a key event that governs tumor progression and metastasis. It is
controlled by the complicated and coordinated actions of pro-angiogenic factors and their …

Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer

M Anderson, R Marayati, R Moffitt, JJ Yeh - Oncotarget, 2016 - pmc.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a KRAS-driven cancer with a high incidence
of metastasis and an overall poor prognosis. Previous work in a genetically engineered …

Channeling the force: Piezo1 mechanotransduction in cancer metastasis

JA Dombroski, JM Hope, NS Sarna, MR King - Cells, 2021 - mdpi.com
Cancer metastasis is one of the leading causes of death worldwide, motivating research into
identifying new methods of preventing cancer metastasis. Recently there has been …